These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36792010)

  • 21. Antiphospholipid Syndrome: State of the Art of Clinical Management.
    Depietri L; Veropalumbo MR; Leone MC; Ghirarduzzi A
    Cardiovasc Drugs Ther; 2023 Aug; ():. PubMed ID: 37572208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspective.
    Pengo V; Denas G
    Thromb Res; 2018 Sep; 169():35-40. PubMed ID: 30007134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful secondary thromboprophylaxis with direct oral anticoagulants for a patient with catastrophic antiphospholipid syndrome: A case report.
    Dinh NH; Cheanh Beaupha SM
    Medicine (Baltimore); 2020 Jun; 99(26):e20811. PubMed ID: 32590766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catastrophic antiphospholipid syndrome: is life-long anticoagulation therapy required?
    Mesa CJ; Rife EC; Espinoza LR
    Clin Rheumatol; 2020 Jul; 39(7):2115-2119. PubMed ID: 32107665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission.
    Pineton de Chambrun M; Larcher R; Pène F; Argaud L; Demoule A; Jamme M; Coudroy R; Mathian A; Gibelin A; Azoulay E; Tandjaoui-Lambiotte Y; Dargent A; Beloncle FM; Raphalen JH; Couteau-Chardon A; de Prost N; Devaquet J; Contou D; Gaugain S; Trouiller P; Grangé S; Ledochowski S; Lemarie J; Faguer S; Degos V; Combes A; Luyt CE; Amoura Z;
    J Autoimmun; 2019 Sep; 103():102292. PubMed ID: 31253464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome.
    Sciascia S; Lopez-Pedrera C; Cecchi I; Pecoraro C; Roccatello D; Cuadrado MJ
    Rheumatology (Oxford); 2016 Oct; 55(10):1726-35. PubMed ID: 26843482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catastrophic antiphospholipid syndrome; a "CATASTROPHIC" case of systemic lupus erythematosus.
    Roberts JR; Finger DR
    Hawaii Med J; 2004 Dec; 63(12):362-4. PubMed ID: 15704545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe thrombotic events associated with pre-procedural interruption of anticoagulation in systemic lupus erythematosus with secondary antiphospholipid syndrome: Cases and literature review.
    Anderson M; Belmont HM
    Lupus; 2022 Feb; 31(2):261-267. PubMed ID: 35041558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome.
    Fonseca MES; Balbi GGM; Signorelli F; Gouvea CP; de Andrade DCO
    Lupus; 2022 Apr; 31(5):565-574. PubMed ID: 35266798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catastrophic antiphospholipid syndrome and pregnancy: an experience of 13 cases.
    Hanouna G; Morel N; Le Thi Huong D; Josselin L; Vauthier-Brouzes D; Saadoun D; Kettaneh A; Levesque K; Le Guern V; Goffinet F; Carbonne B; Amoura Z; Piette JC; Nizard J; Costedoat-Chalumeau N
    Rheumatology (Oxford); 2013 Sep; 52(9):1635-41. PubMed ID: 23676524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the "CAPS Registry".
    López-Benjume B; Rodríguez-Pintó I; Amigo MC; Erkan D; Shoenfeld Y; Cervera R; Espinosa G;
    Autoimmun Rev; 2022 Apr; 21(4):103055. PubMed ID: 35085802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects.
    Islabão AG; Trindade VC; da Mota LMH; Andrade DCO; Silva CA
    Paediatr Drugs; 2022 Jan; 24(1):13-27. PubMed ID: 34904182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials.
    Adelhelm JBH; Christensen R; Balbi GGM; Voss A
    Lupus Sci Med; 2023 Oct; 10(2):. PubMed ID: 37899090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort study.
    Guédon AF; Catano J; Ricard L; Laurent C; de Moreuil C; Urbanski G; Deriaz S; Gerotziafas G; Elalamy I; Audemard A; Chasset F; Alamowitch S; Sellam J; Maillot F; Boffa JJ; Cohen A; Abisror N; Fain O; Mekinian A
    Arthritis Res Ther; 2022 Jan; 24(1):33. PubMed ID: 35078523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Catastrophic antiphospholipid syndrome].
    Costedoat-Chalumeau N; Arnaud L; Saadoun D; Chastre J; Leroux G; Cacoub P; Amoura Z; Piette JC
    Rev Med Interne; 2012 Apr; 33(4):194-9. PubMed ID: 22341856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report.
    Ruffatti A; De Silvestro G; Marson P; Tonello M; Calligaro A; Favaro M; Del Ross T; Hoxha A; Mattia E; Pengo V
    J Autoimmun; 2018 Sep; 93():124-130. PubMed ID: 30146007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature.
    Marco-Rico A; Marco-Vera P
    Semin Thromb Hemost; 2023 Oct; 49(7):736-743. PubMed ID: 36996874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series.
    Madison JA; Gockman K; Hoy C; Tambralli A; Zuo Y; Knight JS
    Pediatr Rheumatol Online J; 2022 Feb; 20(1):17. PubMed ID: 35197077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemorrhagic complications of long-term anticoagulant therapy in 7 patients with systemic lupus erythematosus and antiphospholipid syndrome.
    al-Sayegh FA; Ensworth S; Huang S; Stein HB; Klinkhoff AV
    J Rheumatol; 1997 Sep; 24(9):1716-8. PubMed ID: 9292793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dabigatran for catastrophic antiphospholipid syndrome.
    Sarrate E; Olive A; Morales-Indiano C; Santos-Gómez M; Orna E; Monreal M; Sorigue M
    Blood Coagul Fibrinolysis; 2019 Oct; 30(7):364-365. PubMed ID: 31464688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.